The University of Surrey today announced that it is to lead a major European research initiative in the genetics of drug addiction, funded by an € 8.1 million contract from the European Commission. The effort brings together eight leading public and private research organisations with the aim of identifying genes involved in addiction and advancing the development of new treatment strategies for this serious disease.
Although the role of genetics in susceptibility to addiction has been recognised for some time, the complexity of the disease and the importance of familial environmental risk factors have made isolating genes a formidable challenge. To meet it, this initiative will combine human population genetics with powerful animal genetics and gene-expression strategies. Reykjavik-based deCODE genetics, a biopharmaceutical company and world leader in gene discovery in common diseases, will head the human genetics effort, working with Iceland’s National Center of Addiction Medicine (SAA).
Professor Ian Kitchen of the School of Biomedical and Molecular Sciences at the University of Surrey, who heads the research programme said “It is very exciting to be able to bring together the capabilities of eight leading groups across Europe. An understanding of the genetics of addiction may give us new insight into the biological basis of addiction and the dysfunction of the addicted brain. This may serve as a first step toward developing treatments that can fight drug craving and relapse, instead of focusing solely on the symptoms of drug withdrawal as we do today”.
Stuart Miller | alfa
NIH scientists describe potential antibody treatment for multidrug-resistant K. pneumoniae
14.03.2018 | NIH/National Institute of Allergy and Infectious Diseases
Researchers identify key step in viral replication
13.03.2018 | University of Pittsburgh Schools of the Health Sciences
For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of live zebrafish embryos. This innovative approach using artificial organelles as cellular implants offers new potential in treating a range of diseases, as the authors report in an article published in Nature Communications.
In the cells of higher organisms, organelles such as the nucleus or mitochondria perform a range of complex functions necessary for life. In the networks of...
Animal photoreceptors capture light with photopigments. Researchers from the University of Göttingen have now discovered that these photopigments fulfill an...
On 15 March, the AWI research aeroplane Polar 5 will depart for Greenland. Concentrating on the furthest northeast region of the island, an international team...
The world’s second-largest ice shelf was the destination for a Polarstern expedition that ended in Punta Arenas, Chile on 14th March 2018. Oceanographers from...
At the 2018 ILA Berlin Air Show from April 25–29, the Fraunhofer Institute for Laser Technology ILT is showcasing extreme high-speed Laser Material Deposition (EHLA): A video documents how for metal components that are highly loaded, EHLA has already proved itself as an alternative to hard chrome plating, which is now allowed only under special conditions.
When the EU restricted the use of hexavalent chromium compounds to special applications requiring authorization, the move prompted a rethink in the surface...
19.03.2018 | Event News
16.03.2018 | Event News
13.03.2018 | Event News
19.03.2018 | Physics and Astronomy
19.03.2018 | Materials Sciences
19.03.2018 | Event News